What is the debt of PeptiDream this year?
PeptiDream has a debt level of 2,712.84 JPY this year.
PeptiDream Debt 2024
PeptiDream Debt
2,712.84 JPY
Ticker
4587.T
ISIN
JP3836750004
WKN
A1W0KK
In 2024, PeptiDream's total debt was 2,712.84 JPY, a -82.83% change from the 15,800.78 JPY total debt recorded in the previous year.
PeptiDream Aktienanalyse
What does PeptiDream do?
PeptiDream Inc is a Japanese biotech company specializing in novel therapeutics and drugs. The company was founded in 2006 by Professor Hiroaki Suga, who established the field of peptide synthesis at the University of Tokyo. Peptides are short chains of amino acids used in pharmaceutical development and diagnosis. PeptiDream uses a patented technology to generate billions of different peptides, which can then be systematically tested for functionality and applicability. The company also utilizes artificial intelligence and machine learning to specifically find compounds that can potentially treat cancer or neurodegenerative diseases. PeptiDream has four diverse business areas focusing on different applications. The first area is the identification of new drugs, where the company collaborates with several pharmaceutical and biotech firms to develop new compounds. The second area focuses on the development of peptide-based diagnostics. An example of this is the PeelAVERT technology, which identifies cancer-causing proteins through a "peeling process" of skin samples. This allows for personalized cancer treatment and improves success rates. The third area involves the development of agrochemicals. PeptiDream aims to replace chemical pesticides with biodegradable peptide-based compounds that have no negative impact on the environment. The fourth area aims to enhance quality of life through the use of peptides. The company focuses on compounds that can strengthen the immune system or slow down the aging process. PeptiDream has made several groundbreaking discoveries, including the PD-1 inhibitor technology for cancer treatment. This method uses peptides to activate the body's immune system and kill cancer cells. PD-1 inhibitors have shown promising results in clinical studies for lung cancer, kidney cancer, and other tumor types. PeptiDream has also developed a technology called "Peptide Discovery Platform System 2.0," which allows for the rapid generation and analysis of billions of diverse peptides. This method has been patented and enables PeptiDream to quickly focus on the development of new compounds. PeptiDream is a global leader in the development of peptide therapeutics and diagnostics. The company has earned an excellent reputation and collaborates closely with various research institutions, pharmaceutical companies, and biotech firms. PeptiDream also invests in training the next generation of scientists and strives to provide the industry and society with new compounds. PeptiDream ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding PeptiDream's Debt Structure
PeptiDream's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing PeptiDream's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to PeptiDream’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in PeptiDream’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about PeptiDream stock
What was the debt of PeptiDream compared to the previous year?
The debt of PeptiDream has increased by -82.83% compared to the previous year dropped.
What are the consequences of high debt for investors in PeptiDream?
High debt can pose a risk for investors of PeptiDream, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of PeptiDream?
Low debt means that PeptiDream has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from PeptiDream affect the company?
An increase in debt of PeptiDream can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of PeptiDream affect the company?
A reduction in debt of PeptiDream can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of PeptiDream?
Some factors that can influence the debt of PeptiDream include investments, acquisitions, operating costs, and revenue development.
Why are the debts of PeptiDream so important for investors?
The debts of PeptiDream are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can PeptiDream take to change the debt?
To change the debt, PeptiDream can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does PeptiDream pay?
Over the past 12 months, PeptiDream paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, PeptiDream is expected to pay a dividend of 0 JPY.
What is the dividend yield of PeptiDream?
The current dividend yield of PeptiDream is .
When does PeptiDream pay dividends?
PeptiDream pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of PeptiDream?
PeptiDream paid dividends every year for the past 0 years.
What is the dividend of PeptiDream?
For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.
In which sector is PeptiDream located?
PeptiDream is assigned to the 'Health' sector.
Wann musste ich die Aktien von PeptiDream kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of PeptiDream from 10/1/2024 amounting to 0 JPY, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.
When did PeptiDream pay the last dividend?
The last dividend was paid out on 10/1/2024.
What was the dividend of PeptiDream in the year 2023?
In the year 2023, PeptiDream distributed 0 JPY as dividends.
In which currency does PeptiDream pay out the dividend?
The dividends of PeptiDream are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von PeptiDream
Our stock analysis for PeptiDream Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PeptiDream Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
